T0	Interventions 506 557	status of BRAF c.1799T>A (p.V600E) mutation and MSI
T1	Interventions 631 692	chemotherapy trial [5-fluorouracil and leucovorin (FU/LV) vs.
T2	Interventions 693 729	irinotecan (CPT11), FU and LV (IFL);
T3	Interventions 874 886	chemotherapy
T4	Interventions 1490 1493	IFL
T5	Interventions 1501 1506	FU/LV
T6	Interventions 1599 1602	IFL
T7	Interventions 1645 1650	FU/LV
T8	Interventions 1893 1918	irinotecan-based therapy.